Skip to main content

Advertisement

Log in

The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

The social or familial factors influencing the location chosen for end-of-life (EOL) care for terminally ill breast cancer patients are unknown.

Methods

We retrospectively analyzed 195 patients with recurrent or progressive breast cancer who received anticancer treatment at the National Cancer Center Hospital between January 2008 and May 2012. Detailed data concerning the patients’ demographic, familial, and clinical characteristics were collected, and multivariate and Cox logistic regression analyses were performed to evaluate the impact of these characteristics on the place of EOL care and on survival, respectively.

Results

Sixty-eight patients (34.9 %) died in a hospital, 26 patients (13.3 %) at home, and 101 patients (51.8 %) in hospice. Most of the patients having caregivers received EOL care at palliative care facilities (hospice or home) [odds ratio (OR) 2.57; 95 % confidence interval (CI) 1–6.6; p = 0.05]. In contrast, patients with factors suggesting a clinically severe status (performance status ≥2, use of opioids, delirium, and ascites) more often received EOL care in a hospital. Among patients who received EOL care at hospice or home, patients with minor children received EOL care at home (OR 0.08; 95 % CI 0.02–0.38; p = 0.001). Patients with brain metastases chose hospice (OR 12.37; 95 % CI 2.25–68.13; p = 0.004). Furthermore, having a caregiver was associated with prolonged survival (hazard ratio 0.62; 95 % CI 0.39–0.97; p = 0.035).

Conclusion

Familial factors such as having children and caregivers significantly influenced the place of EOL care for terminally ill breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. National Cancer Center Cancer Information Service. Japanese cancer statistics [in Japanese]. National Cancer Center, Tokyo, Japan. 2015. Available at: http://ganjoho.jp/public/statistics/index.html. Accessed May 23, 2015.

  2. Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3:287–300.

    Article  CAS  PubMed  Google Scholar 

  3. Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458–65.

    Article  PubMed  Google Scholar 

  4. Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353–63.

    Article  CAS  PubMed  Google Scholar 

  5. Bruera E, Russell N, Sweeney C, et al. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol. 2002;20:2127–33.

    Article  PubMed  Google Scholar 

  6. Burge F, Lawson B, Johnston G. Trends in the place of death of cancer patients, 1992-1997. CMAJ. 2003;168:265–70.

    PubMed  PubMed Central  Google Scholar 

  7. Sanjo M, Miyashita M, Morita T, et al. Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan. Ann Oncol. 2007;18:1539–47.

    Article  CAS  PubMed  Google Scholar 

  8. Yamagishi A, Morita T, Miyashita M, et al. Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care. 2008;25:412–8.

    PubMed  Google Scholar 

  9. Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–8.

    Article  PubMed  Google Scholar 

  10. Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22:3438–40.

    Article  PubMed  Google Scholar 

  11. Alonso-Babarro A, Bruera E, Varela-Cerdeira M, et al. Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol. 2011;29:1159–67.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Grendarova P, Sinnarajah A, Trotter T, et al. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010. Support Care Cancer. 2015;23:3059–67.

    Article  PubMed  PubMed Central  Google Scholar 

  13. O’Connor TL, Ngamphaiboon N, Groman A, et al. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med. 2015;18:50–5.

    Article  PubMed  Google Scholar 

  14. Morita T, Oyama Y, Cheng SY, et al. Palliative care physicians’ attitudes toward patient autonomy and a good death in East Asian Countries. J Pain Symptom Manage. 2015;50(190–199):e191.

    Google Scholar 

  15. Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23:2637–44.

    Article  PubMed  Google Scholar 

  16. Okamura H, Uchitomi Y, Sasako M, et al. Guidelines for telling the truth to cancer patients. Japanese National Cancer Center. Jpn J Clin Oncol. 1998;28:1–4.

    Article  CAS  PubMed  Google Scholar 

  17. Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci. 1997;809:290–9.

    Article  CAS  PubMed  Google Scholar 

  18. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.

    Article  CAS  PubMed  Google Scholar 

  19. Braga S, Miranda A, Fonseca R, et al. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psycho-oncology. 2007;16:863–8.

    Article  PubMed  Google Scholar 

  20. Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009;20:1555–9.

    Article  CAS  PubMed  Google Scholar 

  21. Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–91.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–6.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30:4380–6.

    Article  PubMed  Google Scholar 

  24. Akiyama M, Takebayashi T, Morita T, et al. Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan. Support Care Cancer. 2012;20:923–31.

    Article  PubMed  Google Scholar 

  25. Morita T, Miyashita M, Shibagaki M, et al. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage. 2006;31:306–16.

    Article  PubMed  Google Scholar 

  26. Nishie H, Mizobuchi S, Suzuki E, et al. Living will interest and preferred end-of-life care and death locations among Japanese adults 50 and over: a population-based survey. Acta Med Okayama. 2014;68:339–48.

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a public grant from the Ministry of Health, Labor, and Welfare of Japan (H24-GanRinSho-Wakate-001).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenichi Harano.

Ethics declarations

Conflict of interest

The authors have no potential conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harano, K., Yonemori, K., Hirakawa, A. et al. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study. Breast Cancer 23, 797–806 (2016). https://doi.org/10.1007/s12282-015-0643-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-015-0643-6

Keywords

Navigation